معرفی
Imran Siddiqi, MD, PhD is an Associate Professor of Clinical Pathology at the Keck School of Medicine, University of Southern California. He serves as Medical Director of Hematology Labs at Keck Hospital and Norris Hospital. His expertise focuses on hematopathology, with a strong emphasis on lymphoma, leukemia, and molecular diagnostics. Dr. Siddiqi's research explores genomic drivers in hematologic malignancies, diagnostic methodologies, and therapeutic targets in cancers like myelofibrosis and prostate cancer.
His work bridges clinical practice and translational research, including studies on novel therapies (e.g., Smoothened inhibitors for myelofibrosis) and diagnostic tools like point-of-care hematology analyzers. He addresses diagnostic challenges in rare conditions such as VEXAS syndrome and myelokathexis, contributing to improved patient management strategies.
Publications highlight his focus on lymphoma subtypes (e.g., mantle cell lymphoma, T-cell prolymphocytic leukemia) and their genetic underpinnings. His recent studies also investigate radiomics in renal cell carcinoma and donor selection in hematopoietic stem cell transplantation for Hispanic patients with B-cell ALL.
Dr. Siddiqi’s contributions span over 100 peer-reviewed articles, reflecting his dedication to advancing diagnostic precision and therapeutic innovation in hematology and oncology.
